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Objective: 20-Hydroxyeicosatetraenoic acid (20-HETE), an important bioactive lipid metabolite, has recently been 
identified to be a novel contributor of angiogenesis secondary to ischemia. Moreover, an inflammatory response is 
required for the initiation of ischemic angiogenesis, in response to ischemic tissue injury. The goal of this study is 
to investigate the role of inflammation in 20-HETE regulation of ischemia-induced angiogenesis.  
Methods: We first established a mouse hind limb ischemia model for immunocompetent Balb/C mice and 
immunodeficient NOD-SCID mice by femoral artery ligation. Groups of Balb/C and NOD-SCID mice were 
administered a 20-HETE synthesis inhibitor, DDMS, or saline as a solvent control. Laser Doppler perfusion imaging 
(LDPI) was used to visualize and quantify blood perfusion on days 0, 1, 3, 7, 14, and 21 post ligation, confirmed by 
microvessel density analysis. LC/MS/MS analysis was performed on day 3 post ligation on ischemic and non-
ischemic control gracilis muscles to measure 20-HETE levels. Additionally, an antibody to lymphocyte antigen 6 
complex (Ly6G/C) was administered to neutralize the infiltration of neutrophils, macrophages, and monocytes. 20-
HETE levels were again measured on day 3 post ligation in these mice.    
Results: Quantification of the compensatory blood perfusion recovery post ischemia by LDPI showed that 
immunocompetent Balb/C control mice demonstrated a normal course of the compensatory angiogenic response 
while NOD-SCID immunodeficient mice showed a significantly decreased response. Additionally, DDMS was shown 
to inhibit the compensatory response in Balb/C mice, while no inhibitory effect was observed in immunodeficient 
NOD-SCID mice.  This observation is confirmed by a marked decrease in microvessel density in SCID mice (1.5±0.2) 
post ischemia compared to immunocompetent Balb/C mice (2.65±0.32). As expected, ischemia markedly 
increased 20-HETE levels in the ischemic gracilis muscle of Balb/C mice by 6-fold (6±2 in non-ischemic vs 27±5 
pg/mg in ischemic), while levels in NOD-SCID mice showed no change between the ischemic and non-ischemic 
control. Lastly, Balb/C mice that were treated with Ly6G/C neutralizing antibody exhibited significantly decreased 
20-HETE levels in their ischemic gracilis muscle compared to the non-ischemic control.  
Conclusion: Inflammation may be an essential contributor in 20-HETE regulation of the ischemia-induced 
angiogenic response. 
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1. Immunodeficient NOD-SCID mice show a decreased compensatory blood 
perfusion recovery as compared to immunocompetent Balb/C mice, indicating that 
the presence of immunity may lead to a more significant and prolonged 
compensatory angiogenic response.  
 
2. Furthermore, 20-HETE synthesis inhibitor, DDMS decreased compensatory 
response in Balb/C mice, but had no such effect on NOD-SCID mice.  
 
3. Consistently, Balb/C mice show an increased MVD on day 21 in the ischemic limb 
gracilis muscle compared to immunodeficient NOD-SCID mice, supporting a 
decrease angiogenic response in this immunodeficient model. 
 
Taken together, these data strongly support a potential role of immunity in 20-
HETE regulated ischemic angiogenesis. 
 
4. NOD-SCID mice show virtually no difference in 20-HETE production post 
ischemia when compared to Balb/c mice.  
 
5. Targeted depletion of neutrophils, macrophages, and monocytes using Ly6G/C 
antibody in immunocompetent Balb/C mice results in a marked lower 20-HETE 
levels post ischemia.  
 
These findings implicate that inflammatory cells may contribute to increased 20-
HETE production during compensatory angiogenesis.  
Inflammation may be an essential 
contributor in 20-HETE regulation of 
ischemia-induced angiogenic response. 
Figure 1C. Microvessel density (MVD) analysis of Balb/C and SCID non-ischemic and 
ischemic limbs. Gracilis muscles were excised from ischemic and nonischemic limbs at 
the end of the 21 day period, and were sectioned and stained with CD31 and tomato 
lectin. The number of muscle fibers and capillaries were counted in each field. Results: 
Balb/C mice have a significantly higher MVD than SCID mice, consistent with a 
decreased angiogenic response in SCID mice. 
Figure 1B: Quantitation of recovery of blood perfusion secondary to ischemia. Blood 
perfusion for days 0, 1, 3, 7, 14, and 21 were quantified and plotted for Balb/C control, Balb/C 
DDMS, SCID control, and SCID DDMS groups. Results: The Balb/C controls underwent normal 
courses of compensatory angiogenesis as we have previously published, whereas SCID 
controls showed a significantly decreased compensatory response. As previously 
demonstrated, DDMS decreased compensatory blood perfusion in Balb/C mice. 
Interestingly, we see no effect of DDMS on blood perfusion post-ischemia in NOD-SCID 
mice. On the third day after ligation, SCID mice seem to have an increase in blood flow, but 
the delta of the SCID curve is skewed by this increase. Without day 3 data, there is no 
change in blood flow. 
Figure 1A: Representative Laser Doppler Perfusion Imaging Scans for Balb/C and SCID 
mice are shown from days 0, 1, 3, and 21 post ligation. Blood perfusion was used an one of 
the indexes of  compensatory angiogenesis. Results: Immunodeficient NOD-SCID mice 
display a decreased compensatory blood perfusion recovery compared to 
immunocompetent Balb/C mice. 
Figure 2: Comparison of 20-HETE levels in hind limb gracilis muscles of Balb/C, SCID, 
and Ly6G/C treated Balb/C mice before and after ischemia. Femoral artery ligations 
were performed in Balb/c, SCID, and Balb/c mice treated with 0.5mg of Ly6G/C 
antibody (i.p.). Ly6G/C targets and depletes neutrophils, macrophages, and 
monocytes. On day 3 post-ligation, gracilis muscles were excised from both the 
ischemic and non-ischemic hind limbs of Balb/C and SCID mice and were quantified 
for 20-HETE levels by LC/MS/MS analysis. 20-HETE levels were normalized to total 
protein. Results: Ischemic muscles in Balb/C mice have a 6-fold increase in 20-HETE 
compared to contralateral non-ischemic muscles, while SCID mice have no 
difference in 20-HETE levels between ischemic and non-ischemic muscles. Balb/C 
treated with Ly6G/C antibody showed decreased 20-HETE production post ligation in 
the ischemic limb. 20-HETE levels in Ly6G/C treated Balb/C mice were closer to basal 
levels of 20-HETE production. 
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 20-HETE is an arachidonic acid derived eicosanoid, mainly synthesized by the enzyme cytochrome P450 (CYP450) 4A 
and 4F. Previous studies by our group (Chen et al, 2014; Guo et al, 2011; Guo et al, 2007) have demonstrated that 20-HETE 
regulates both endothelial cell (EC) and endothelial progenitor cell (EPC) functions that are associated with angiogenesis.  
 Our recent publication (Chen et al, 2016) further demonstrated that 20-HETE is a novel contributor of ischemia-
induced angiogenesis in vivo based on the following two important findings: 1) Pharmacological 20-HETE interference 
significantly inhibited the compensatory angiogenesis secondary to ischemia; and 2) ischemia markedly stimulated the 
production of 20-HETE in the hindlimb gracilis muscle where angiogenesis is taken place. The precise cellular origin of the 
increased 20-HETE and the molecular mechanism underlying 20-HETE regulation in ischemia-induced angiogenesis remain 
unknown. 
  After ischemic injury, inflammatory cytokines are quickly produced and immune cells are recruited to the site of 
injury. The first inflammatory cells to arrive at the site of injury are neutrophils, which then recruit macrophages through 
the release of additional cytokines (Parham, 2014). Thus, inflammatory cells play an important role in mediating ischemic 
angiogenesis.  
 In the current study, we aim to determine the role of inflammation in 20-HETE regulation of ischemia-induced 
angiogenesis. We hypothesized that the  inflammatory response may contribute to increased 20-HETE that regulates 
ischemia-induced angiogenesis in vivo.   
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Figure 3: Proposed model of ischemia induced production of 20-HETE leading to 
compensatory neovascularization. After injury, 20-HETE levels in ischemic tissue 
are increased which leads to production of angiogenic factors such as HIF and 
VEGF and progressive compensatory neovascularization. The source of 20-HETE is 
unknown, but proposed potential sources may be inflammatory cells, EC, or EPC. 
 
